台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    85.7
  • 漲跌
    ▲0.9
  • 漲幅
    +1.06%
  • 成交量
    82
  • 產業
    上市 生技醫療類股
  • 353人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
旭富 (4119)籌碼相關-富邦-永和 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-永和 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/2200.00184.8085.70-1272-0.37%
2025/01/17184.0000.0084.2012720.37%
2025/01/16184.1000.0084.0012710.37%
2025/01/134.183.5300.0083.904.12691.52%
2025/01/101.186.7300.0085.801.12590.42%
2025/01/0900.00089.5088.5002510.00%
2025/01/0800.00190.0089.80-1247-0.40%
2024/12/19190.0000.0089.9012450.41%
2024/12/16190.1000.0090.3012420.41%
2024/12/130.191.3000.0090.600.12380.04%
2024/12/1100.00093.9094.0002290.00%
2024/12/09094.40694.2293.40-6224-2.66%
2024/12/0200.00496.5096.10-4204-1.96%
2024/11/26296.1000.0095.5021931.04%
2024/11/2200.00398.0097.50-3181-1.65%
2024/11/2000.0010.198.0897.80-10.1172-5.85%
2024/11/13395.7300.0096.0031362.20%
2024/11/12194.20293.6094.30-1123-0.81%
2024/11/1100.001.393.3893.30-1.3112-1.11%
2024/11/06189.10189.2089.400960.00%
2024/10/0900.00191.6091.40-1135-0.74%
2024/10/07192.3000.0092.2011350.74%
2024/09/300.189.5000.0089.800.11330.07%
2024/09/090.186.1000.0086.500.11590.06%
2024/09/04286.90187.0087.0011650.60%
2024/08/130.190.0000.0089.500.11980.05%
2024/08/06185.4000.0088.9012180.46%
2024/08/058.187.01186.8086.607.12143.29%
2024/08/02190.9000.0091.0012050.49%
2024/07/31190.7000.0091.2012040.49%
2024/07/22091.6000.0090.8002020.00%
2024/07/191.191.6000.0091.601.12010.52%
2024/07/1100.00191.5091.80-1203-0.49%
2024/07/09191.1000.0091.8012050.49%
2024/07/080.591.1800.0091.300.52030.25%
2024/07/05191.0000.0091.3012030.49%
2024/07/04192.0000.0091.2012050.49%
2024/07/0300.000.191.3091.40-0.1206-0.03%
2024/07/0200.001.191.3091.20-1.1206-0.53%
2024/06/28390.17190.1090.4022050.97%
2024/06/24189.9000.0089.7012040.49%
2024/06/21290.2000.0090.3022060.97%
2024/06/20090.3000.0090.2002060.01%
2024/06/1900.00190.5090.20-1205-0.49%
2024/06/170.491.0000.0090.800.42080.17%
2024/06/140.190.1200.0090.100.12100.05%
2024/06/110.290.8000.0090.200.22140.07%
2024/06/0700.00192.9093.10-1216-0.46%
2024/06/03292.4000.0092.4022310.87%
2024/05/31192.00092.3092.0012300.43%
2024/05/3000.00092.4092.5002300.00%
2024/05/28492.7000.0092.5042351.70%
2024/05/27393.0000.0093.1032341.28%
2024/05/241.191.3000.0091.901.12330.45%
2024/05/23291.4500.0091.3022350.85%
2024/05/22192.0000.0092.4012350.42%
2024/05/21292.35192.1092.1012350.42%
2024/05/20192.5000.0093.4012330.43%
2024/05/1700.00293.2093.90-2230-0.87%
2024/05/16292.5000.0092.5022250.89%
2024/05/1500.000.191.3091.50-0.1222-0.06%
2024/05/13191.70491.7591.80-3232-1.29%
2024/05/10290.902.490.7490.90-0.4240-0.15%
2024/05/06188.6000.0088.5012420.41%
2024/04/3000.00188.9089.00-1245-0.41%
2024/04/2600.00389.1089.00-3245-1.22%
2024/04/2500.00388.7088.50-3245-1.22%
2024/04/19186.30187.7086.4002540.00%
2024/04/18188.6000.0088.3012500.40%
2024/04/16187.4000.0087.4012490.40%
2024/04/09089.2000.0088.9002610.00%
2024/04/0300.00188.1087.80-1258-0.39%
2024/03/29188.3000.0088.4012580.39%
2024/03/26087.6300.0087.2002600.01%
2024/03/25088.0000.0087.6002610.00%
2024/03/21287.6000.0087.7022740.73%
2024/03/200.187.8000.0087.600.12780.04%
2024/03/1900.00088.7087.9002800.00%
2024/03/1500.000.587.9087.40-0.5285-0.16%
2024/03/131.187.6800.0087.901.12850.39%
2024/03/110.189.5000.0089.100.12750.02%
2024/03/08792.0900.0090.4072732.56%
2024/03/070.190.6000.0090.500.12690.02%
2024/02/2900.00191.3091.20-1281-0.36%
2024/02/2200.00191.6091.30-1283-0.35%
2024/02/1900.00191.4091.50-1285-0.35%
2024/02/160.290.7000.0090.600.22850.05%
2024/02/15289.9500.0089.9022930.68%
2024/02/05391.37190.9091.1022910.69%
2024/02/023.490.38390.6790.800.42900.14%
2024/02/011.192.4600.0092.301.12990.37%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章